Nomifensine in hyperprolactinemic states
- 1 August 1984
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 7 (4) , 421
- https://doi.org/10.1007/bf03351028
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Nomifensine, TRH and insulin-induced hypoglycemia tests in the diagnosis of prolactinomasJournal of Endocrinological Investigation, 1983
- Comparison of the Responses in the Nomifensine Test with Hyperprolactinemia due to Prolactin-Secreting Pituitary Tumors and Nonprolactin-Secreting Hypothalamic Tumors*Journal of Clinical Endocrinology & Metabolism, 1981
- EVALUATION OF TWO INHIBITORY TESTS (NOMIFENSINE AND L‐DOPA + CARBIDOPA) FOR THE DIAGNOSIS OF HYPERPROLACTINAEMIC STATESClinical Endocrinology, 1980
- Effect of Central Nervous System Dopaminergic Activation on Prolactin Secretion in Man: Evidence for a Common Central Defect in Hyperprolactinemic Patients with and without Radiological Signs of Pituitary Tumors*Journal of Clinical Endocrinology & Metabolism, 1980
- Prolactin Responsiveness to Nomifensine in Patients with Hyperprolactinemia of Tumorous or Uncertain Etiology*Journal of Clinical Endocrinology & Metabolism, 1980
- A new pharmacological approach to the diagnosis of hyperprolactinaemic states: the nomifensine testActa Endocrinologica, 1980
- Failure of Nomifensine Administration to Discriminate between Tumorous and Nontumorous Hyperprolactinemia*Journal of Clinical Endocrinology & Metabolism, 1980
- Nomifensine: Diagnostic Test in Hyperprolactinemic States*Journal of Clinical Endocrinology & Metabolism, 1978